120 related articles for article (PubMed ID: 9557050)
1. [Use of mucolytic preparations (Mucosolvan) in selected diseases of the upper respiratory tract. Part II].
Szmeja Z; Golusiński W; Mielcarek-Kuchta D; Laczkowska-Przybylska J
Otolaryngol Pol; 1997; 51(5):480-6. PubMed ID: 9557050
[TBL] [Abstract][Full Text] [Related]
2. [The use of mucolytic preparations (Mucosolvan) in nasal and paranasal sinuses in children].
Golusiński W; Szmeja Z; Szyfter W; Kruk-Zagajewska A; Mielcarek-Kuchta D; Laczkowska-Przybylska J
Otolaryngol Pol; 1996; 50(6):599-606. PubMed ID: 9173390
[TBL] [Abstract][Full Text] [Related]
3. [Estimation of effectiveness of peroral mucolytic agents in treatment of inflammatory diseases of middle ear and paranasal sinusitis].
Dzhaparidze ShV; Gegenava KhA; Dzhashi MM; Lomidze LS; Nakudashvili NK
Georgian Med News; 2007 Apr; (145):36-8. PubMed ID: 17525496
[TBL] [Abstract][Full Text] [Related]
4. [The use of mucosolvan in ENT diseases. Part I].
Szmeja Z; Golusiński W; Szyfter W; Kruk-Zagajewska A; Mielcarek-Kuchta D
Otolaryngol Pol; 1996; 50(2):162-8. PubMed ID: 9045148
[TBL] [Abstract][Full Text] [Related]
5. Effects and mechanisms of ambroxol inhalation (Mucosolvan
Yang Z; Xiao X; Huang Y; He X; Lu Q; Chen S; Lin Z
Pharmazie; 2017 Oct; 72(10):604-607. PubMed ID: 29441886
[TBL] [Abstract][Full Text] [Related]
6. [Mucolytics in acute and chronic respiratory tract disorders. I. Pathophysiology and mechanisms of action].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 2002 Mar; 12(69):245-7. PubMed ID: 12053600
[TBL] [Abstract][Full Text] [Related]
7. [Clinical observation on Biyan Qingdu Granule and ambroxol hydrochloride in treating secretory otitis media].
Guo Y; Sun XM
Zhong Xi Yi Jie He Xue Bao; 2004 Jul; 2(4):277, 291. PubMed ID: 15339416
[No Abstract] [Full Text] [Related]
8. [Mucolytics in acute and chronic respiratory tract disorders. II. Uses for treatment and antioxidant properties].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 2002 Mar; 12(69):248-52. PubMed ID: 12053601
[TBL] [Abstract][Full Text] [Related]
9. Ambroxol in the 21st century: pharmacological and clinical update.
Malerba M; Ragnoli B
Expert Opin Drug Metab Toxicol; 2008 Aug; 4(8):1119-29. PubMed ID: 18680446
[TBL] [Abstract][Full Text] [Related]
10. Bromhexine for otitis media with effusion.
Roydhouse N
N Z Med J; 1981 Nov; 94(696):373-5. PubMed ID: 7033848
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of letosteine in the treatment of sputum thickening and expectoration difficulty in patients with respiratory diseases: a multicenter, randomized, double-masked, double dummy, positive drug parallel controlled trial.
Zhou Y; Sun S; Liu H; Cui L; Chang X; Sun Z
Pharmazie; 2014 Nov; 69(11):842-9. PubMed ID: 25985582
[TBL] [Abstract][Full Text] [Related]
12. [Clinical trial of a new mucolytic, s-carboxymethylcysteine].
Ghillione de Torviso S
Arch Argent Pediatr; 1971 Aug; 69(6):247-8. PubMed ID: 4941345
[No Abstract] [Full Text] [Related]
13. [Mucolytic therapy for respiratory system diseases. Clinical-experimental results before and after treatment with Transbronchin].
Primer G
Ther Ggw; 1975 Aug; 114(8):1251-66. PubMed ID: 1108276
[No Abstract] [Full Text] [Related]
14. [Efficacy and safety of acute bronchitis treatment in adults--a comparison of Bronchosol® syrup and synthetic preparations with ambroxol. Results of observational study].
Fal AM; Schönknecht K
Wiad Lek; 2015; 68(2):139-44. PubMed ID: 26181148
[TBL] [Abstract][Full Text] [Related]
15. Otitis media with effusion and chronic upper respiratory tract infection in children: a randomized, placebo-controlled clinical study.
Otten FW; Grote JJ
Laryngoscope; 1990 Jun; 100(6):627-33. PubMed ID: 1693411
[TBL] [Abstract][Full Text] [Related]
16. [Inhalation therapy with the new antisecretory drug ambroxol (metabolite VIII of bromhexine) in otorhinolaryngology].
Hoffmann H
Arzneimittelforschung; 1978; 28(5a):931-3. PubMed ID: 581993
[No Abstract] [Full Text] [Related]
17. [Mucolytic and mucoregulatory agents].
Yernault JC
Rev Med Brux; 1987 Oct; 8(8):423. PubMed ID: 3423520
[No Abstract] [Full Text] [Related]
18. [Treatment of secretory otitis media with ambroxol].
Sartoris A
Acta Otorhinolaryngol Ital; 1987; 7 Suppl 16():51-60. PubMed ID: 3334304
[No Abstract] [Full Text] [Related]
19. [Medical treatment of seromucous otitis].
Renou G; Ketari M; Toutée JP; Benzaken J
Rev Laryngol Otol Rhinol (Bord); 1989; 110(3):327-8. PubMed ID: 8638061
[TBL] [Abstract][Full Text] [Related]
20. Mucosolvan serves to optimize perioperative airway management for NSCLC patients in fast track surgery: a randomized placebo controlled study.
Wang JY; Hong X; Chen GH; Li QC; Liu ZM
Eur Rev Med Pharmacol Sci; 2015 Aug; 19(15):2875-81. PubMed ID: 26241543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
